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Abstract Iron deficiency is the primary cause of many wide-
spread nutritional diseases including anemia, pregnancy com-
plications, and infant mortality. Release kinetics of iron pre-
mixes to be mixed with food items like salt, rice, and tea is a
key research objective of many globally active iron fortifica-
tion efforts. Iron release kinetics of microcapsules of two
reverse-enteric coating materials (chitosan and Eudragit
EPO) encapsulating various amounts of ferrous sulfate (10–
40% of total other solids) were done at three pH values (1, 4,
7) for 2 hours. Chitosan and Eudragit microcapsules contained
2.8–5.3% (w/w) and 1.7–9.6% (w/w) iron, respectively,
depicting higher iron loading capacity of Eudragit microcap-
sules. More than 90% iron was released from most samples
within 30 min under stomach conditions (pH 1) and less than
15% ironwas released in 2 h under ambient conditions (pH 7),
showing suitability of both chitosan and Eudragit EPO as
reverse-enteric coatings for iron encapsulation. In terms of
reverse-enteric behavior (RE), Eudragit EPO (RE = 2.4) was
found to be slightly better than chitosan, suggesting the use of
fillers in future research. Higuchi model and Hixson-Crowell
model were found to best fit the data, suggesting a transport
phenomenon governed by both (a) the diffusion process
through the coating material and (b) the dissolution phenom-
enon resulting in decrease in size of the capsules. Results from
this study shall provide guidance for technology development
aspects of various food fortification initiatives and an under-
standing of the iron release from these fortificants during the
food preparation and digestion stages.
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Introduction
Iron deficiency (one of the most common and most wide-
spread nutritional disorders) affects more than two billion
people worldwide, with South East Asian countries, in-
cluding India and Pakistan, being worst affected. In these
countries, women and children from even affluent fami-
lies and upbringings are often anemic (UNICEF 2008),
suggesting a problem with dietary patterns. Cultural con-
siderations involving vegetarianism and frequent fasting,
exacerbated by insufficient intake of iron-rich animal
food and consumption of diets deficient in protein and
ascorbic acid results in low non-heme iron absorption.
A diet rich in iron can cure can cure more than 50% of
anemia cases. Furthermore, iron deficiency leads to a de-
creased absorption of iodine and vitamin A which causes
major additional nutritional disorders (Diosady et al.
2002).
Iron deficiency is readily preventable and is not a common
problem in most of the developed world due to access to multi-
vitamin pills (WHO 2007). Unfortunately, this solution does
not work in developing countries due to poor medical infra-
structure and widespread poverty. Thus, policy intervention by
the government is often desirable to implement various fortifi-
cation strategies. Three main approaches available to target
anemia are fortification, supplementation, and dietary interven-
tions. Amongst them, food fortification is an inexpensive and
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an effective method to increase the intake of iron in the diet
without compromising dietary customs. Several food products,
including salt, rice, sugar, tea, wheat, cereals, and milk, have
been fortified with iron and successful reduction of mortality
has been observed in the test populations (Hurrel 2002). Direct
mixing of iron into food materials is generally not feasible due
to various reactions (redox reaction, iron-polyphenol complex,
etc.) that can happen with food, and change in organoleptic
properties rendering the food unacceptable. As a physical bar-
rier between the food particles and the iron source could pre-
vent unwanted interactions, its development is the subject of
intensive research. Such physical barrier has been produced by
our group through extrusion-based agglomeration, color
masking, coating, spray drying, etc. for producing particles that
mimic the appearance and size of the food particles (Diosady
et al. 2002; Li et al. 2010). Microencapsulation of iron through
spray drying has recently been attempted, and it has been found
that the iron microparticles not only retain bioavailability but
also prevent unpleasant taste, color, and odor in the food matrix
(Dueik and Diosady 2016).
Spray drying is one of the mechanisms used for micro-
encapsulating water-soluble iron salts with desired coating
materials. Spray drying has reliably produced capsules less
than 20 μm in size for the encapsulation of volatile flavors
(Madene et al. 2006), oils (Jafari et al. 2008), microorgan-
isms (Lian et al. 2003) vascular drugs (Vehring 2008), na-
sal drugs (Sun et al. 2009), and sparingly soluble inorganic
nutrients (Oneda and Re 2003), using generally recognized
as safe (GRAS) materials. Spray drying was found suitable
for developing a single-step encapsulating process, simul-
taneously entrapping pigments, excipients, and the iron
source without the complications of a multi-stepped ap-
proach (Romita et al. 2011).
Selection of appropriate coating materials depends greatly
on the end use of the microencapsulated particles (Li et al.
2010) and is an important research objective. For food fortifi-
cation, it is important to consider the fact that food could be
stored in humid places and must not release iron when inside
the mouth, or during cooking etc. So, it is important to block
the release of the iron when pH is around 7. The enteric coating
material remains stable under high acidic condition of stomach
(pH 1.5–3.5) for effective and tailored drug delivery to target
organ (e.g., intestine) while reverse-enteric coating material
readily releases its content at low pH (Dueik and Diosady
2016). Reverse-enteric materials can be used to develop a coat-
ing wherein iron would be protected when added into the food,
but will be released in the stomach. Once the iron is released in
stomach, it is available for absorption in intestines. Dueik and
Diosady (2016) used chitosan and a pharmaceutical-grade
polymer (Eudragit EPO, Evonik Industries) with this behavior.
While chitosan is a linear polysaccharide that has numerous
applications in the food industry due to its ready availability
and biocompatibility, it is insoluble in water and organic sol-
vents and is soluble in dilute aqueous acidic solutions. On the
other hand, Eudragit EPO (Evonik Industries) is a cationic
copolymer based on dimethylaminoethyl methacrylate, butyl
methacrylate, and methyl methacrylate, which is soluble in
gastric fluid up to pH 5.0. Eudragit EPO is available in a
food-grade formulation known as Eudraguard. Its properties
make it useful for moisture protection and taste masking.
Both these coatings are hydrophobic at pH > 6.5 and hydro-
philic at the gastric pH (< 2), which can potentially provide a
good moisture barrier to the coated iron premix without hin-
dering the gastric acid dissolution profile (Kwon 2005).
Various empirical and semi-theoretical models
(Hanscomb and Kraft 2010; Sun et al. 2009) have been
developed for investigating particle formation within
spray dryers. However, no work has been conducted
on modeling the release behavior of such food
fortificants formed after spray drying. In this work, we
have attempted to model the release behavior of reverse-
enteric spray dried microcapsules under different pH
conditions, to understand the inherent phenomena
governing the release of such food fortificants. The iron
fortificants prepared using chitosan and EPO were char-
acterized and compared to assess their applicability for
food fortification. To evaluate how perfectly the coating
materials could encapsulate the iron salt, particle mor-
phology and size distribution analysis was conducted
using scanning electron microscopy (SEM). The release
of iron was analyzed by simulating the conditions of the
stomach and intestine and analyzing Fe using inductive-
ly coupled plasma spectrometry (ICP). The release pro-
file was then fitted to various computational release
models to gather understanding of the phenomenon re-
sponsible for iron release and approximate release times
associated with each microcapsule prepared.
Materials and Methods
Materials
BFood-grade^ ferrous sulfate heptahydrate (Fisher Scientific) was
used as the iron source. Reverse-enteric coated iron microparti-
cles were prepared using either medium molecular weight chito-
san (Sigma Aldrich) or Eudagrit EPO (Evonik Industries) as
coating agents. One percent acetic acid (Fisher Scientific) was
used for enhancing the solubility of chitosan. Eudragit EPO for-
mulation components were stearic acid (Sigma Aldrich), tartaric
acid (BDH Chemicals), and talc (Sigma Aldrich). Stearic acid
was used as it forms a soluble salt with Eudragit, allowing it to
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dissolve at high pH. Sodium lauryl sulfate in the standard phar-
maceutical formulation (Dueik and Diosady 2016) was replaced
by tartaric acid, which is listed as GRAS.
Spray Solution Preparation
All experiments were carried out using distilled water.
Chitosan feed solutions were prepared by dissolving 1%
(w/w) of chitosan in 1% (w/w) acetic acid aqueous solu-
tion and left overnight for complete dissolution. Iron sul-
fate at 15, 20, 30, and 40% of the total weight of the
solids was used to prepare microparticles of various iron
loading. After dissolving ferrous sulfate for 15 min using
a stirrer, the solution was spray dried as described in the
BSpray Drying Conditions, Yield and Output^ section.
Eudragit EPO is used in the pharmaceutical industry in
formulations containing 15% total solids in water, with
the composition of total solids being 57.1:5.7:8.6:28.5
for Eudragit EPO:tartaric acid:stearic acid:talc (Dueik
and Diosady 2016). The spray solution was first prepared
in two halves with talc dispersed in half of the water
needed, and Eudragit EPO, tartaric acid, and stearic acid
dissolved in the other half. The two liquids were mixed
and homogenized for 90 min in a heavy duty laboratory
mixer emulsifier (model L2R, Silverson, England).
Ferrous sulfate at 10, 20, 30, and 40% of total solids
was added and homogenized for 30 more minutes to pre-
pare the feed solution for Eudragit microcapsules.
Spray Drying Conditions, Yield, and Output
All samples were spray dried using a Buchi B290 mini-
spray dryer (Buchi, Switzerland). Chitosan feed solutions
were sprayed at 150 °C with a flow rate of 3 mL/min, an
atomizing gas flow rate of 667 stdL/h at 618 kPa (90 psi)
and an aspirator operating at − 4.5 Pa. In the case of
Eudragit EPO solutions, the operating temperature was
set to 110 °C, while other conditions were kept same.
Later, dried microcapsules were collected from the bottom
of the cyclone separator and were weighed to determine
the process yield and process output. Process yield was
defined as the percentage of the mass of iron premix pro-
duced to the mass of total solids in the liquid spray dried
in a given time and is given by Eq. (1). Process output
was defined as the ratio of the mass of the iron premix
produced to the volume of the liquid spray dried and is
given by Eq. (2).
Yield ¼ mass of iron microcapsules collected
total solids in the spray drying solution
 100% ð1Þ
Process output ¼ mass of iron microcapsules collected
volume of the liquid spray dried
ð2Þ
Morphology, Color, and Size of Microcapsules
Morphology of microcapsules was determined by scan-
ning electron microscopy (SU-3500 VP SEM, Hitachi
High-Technologies). The microcapsules were attached
on SEM stub by carbon conductive double-coated adhe-
sive tape and blast by air to remove any lose particle.
Samples were examined and micrographs were recorded
at an acceleration voltage of 1.5 kV, with working dis-
tance of 51 mm, under high vacuum. The size of the
microcapsules was evaluated using image analysis of the
micrographs using Matlab. The color of the microparti-
cles was measured by taking high-quality photographs
under white lightning and then analyzing the image
using Matlab Image Analysis program.
Total Iron Content and Iron Release Behavior
Total iron content of microcapsules was analyzed by
using ICP-OES. Samples were firs t digested in
microwave-assisted acid digestion system (MARS 6,
John Morris Scientific Pty Ltd.) Briefly, 100 mg of mi-
croparticles was exposed to conc. HNO3 in a closed ves-
sel and raising the temperature (200–210 °C) via micro-
wave irradiation. Iron bound within the matrix solubilizes
in clear digestate. The clear solutions obtained were quan-
titatively poured into a 25-ml flask and brought to volume
with deionized water and further diluted with 5% nitric
acid before analysis. Calibration curve was made with
external iron by diluting a 1000 mg/L standard (Merck)
solution.
In vitro iron bioavailability and iron release were
analyzed according to a previously reported method
(Swain et al. 2003; USP General Chapter 711 2011).
Briefly, the rate of dissolution of iron in 0.1 N HCl
solution (pH 1) was determined, because this solution
resembles gastric juice. Iron release at pH 4 (0.0001 N
HCl solution) was also used as it throws light on coat-
ing integrity (Romita et al. 2011). Iron release in phos-
phate buffer solution adjusted to pH 7 was also used in
this study to estimate the amount of iron released by the
microcapsules during food preparation and swallowing.
The percentage of iron released in 30 min in pH 1
solution was considered to be in vitro bioavailability
of microcapsules. Encapsulation efficiency, defined as
the fraction of iron actually encapsulated in the micro-
capsule, was calculated by dissolving the microcapsules
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in pH 7 solution for 30 min and calculated using Eq.
(3). Percentage of iron released in 1 h in pH 1 and pH
7 solution was used to calculate reverse enteric ratio
(RE) according to Eq. (4):
%Encapsulation efficiency ¼ total iron content−unencapsulated iron released at pH 7
total iron content
 100% ð3Þ





Approximately 20 mg of each spray dried powder
was weighed and dispersed into three 250-ml volumetric
flasks, containing 200 ml each of pH 1 HCl solution,
pH 4 HCl solution, and 200 pH 7 phosphate buffer
solution, respectively. The flasks were then placed in a
shaking water bath set at 37 °C for 2 hours. Five mil-
liliter aliquots from each flask were diluted to 25 ml in
volumetric flasks at various intervals (15, 30, 60, 90,
and 120 min) with 5% nitric acid. The iron content in
the samples was measured using ICP-AES.
Models for Iron Release from Microcapsules
Iron release from these microcapsules was fitted to the five
most common models (Costa and Lobo 2001). A zero-order
model describing the linear fitting between the release time
curves was obtained using Eq. (5):
Y ¼ K0tþ C0 ð5Þ
where Y is the percentage (w/w) of iron released at any specific
time t, and K0 and C0 are the slope and intercept of the y-t
curve.
A first-order model was fitted by plotting the natural loga-
rithm of the percentage of iron left in the encapsulated matrix
with time, expressed by Eq. (6):
ln 100−Yð Þ ¼ K1tþ C1 ð6Þ
where Y is the percentage (w/w) of iron released at any specific
time t, and K1 and C1 are slope and intercept of the ln y vs. t
curve.
A general empirical equation described by Weibull (1951)
was adapted to the release process (Langenbucher 1972). The






where Y is the percentage (w/w) of iron released at any specific
time t, and b and − log a are slope and intercept of the log
[− ln(1 − Y/100)] vs. log t curve.
Higuchi (1963) model, describing a linear relationship be-
tween the percentage of release of the iron and square root of
time, was represented by Eq. (8):
Y ¼ Kht0:5 ð8Þ
where Y is the percentage (w/w) of iron released at any specific
time t, and Kh is the slope of the log Y vs. t
0.5 curve.
Hixson and Crowell (1931) model was used to depict the
condition where the cubic root of the iron left in the matrix
was linear with respect to time. Equation (9) was used to
model this scenario:
100−Yð Þ1=3 ¼ Kstþ Cs ð9Þ
where Y is the percentage (w/w) of iron released at any specific
time t, and Ks and Cs are the slope and intercept of the
(100 − Y)1/3 vs. t curve.
Statistical Analysis
Microsoft Excel (Ver. 15.33, Microsoft Excel for Mac,
Microsoft) was used for regression. Matlab was used for
image analysis of the SEM micrographs. The R2 of the
various fitting equations were compared to assess the
significance of fit. Student’s t test was conducted for
comparing two sets of data to determine if they were
significantly different from each other. All experimental
results were expressed as mean ± standard deviation.
Results and Discussions
Process Yield
The yield of a spray drying process is an important indicator
for the economic feasibility and scalability of the process. The
process yield and process output for the preparation of the
various microcapsules are presented in Table 1. The data in-
dicate that, although the yield from chitosan and Eudragit was
in the same range (65–75%), the process output from Eudragit
was almost 10 times higher than that from the chitosan sam-
ples. This is due to the fact that the total solids in the Eudragit
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spray solution were much higher (~ 15–20%) than those in the
chitosan spray solution (1–2% total solids) due to its higher
viscosity. This effectively translates into a better industrial
process economy while using Eudragit as the coating me-
dium, as less solution has to be processed during the drying
process, leading to 10 times lower processing times. In
other words, spray drying equal volumes of Eudragit and
chitosan solutions will yield 10 times more products from
the former.
A similar yield of 72% was reported for chitosan in a pre-
vious study (Dueik and Diosady 2016). The losses in both our
study and Dueik and Diosady (2016) are mainly on account of
these iron capsules sticking to the instrument wall or passing
through the filter. Amiri-rigi et al. (2011) mentioned that the
high total electric charge formed during the formation of the
microcapsules is responsible for the losses to the instrument
wall. Moreover, lightweight particles are also lost due to the
suction created by the vacuum pump and could only be col-
lected from the air filter of the vacuum pump. An analysis of
these fines revealed that these powders were an order of mag-
nitude smaller in size than the main product (size of the mi-
crocapsules is provided in the BMorphology of the Prepared
Microcapsules^ section).
Morphology of the Prepared Microcapsules
Table 1 presents the L*, a*, and b* of the prepared microcap-
sules after the spray drying process. The color of the micro-
capsules became browner, with more darkness (lower L* val-
ue), redness (higher a* value), and yellowness (higher b*
value), on increasing the iron loading. In both cases, higher
iron loading results in darker premixes. It is noteworthy that
the color of the iron premix often has to be controlled depend-
ing on the purpose of iron fortification. Some formulations,
such as those for fortification of salt or rice, require a whiter
premix, whereas formulations, such as those for tea or coffee
fortification, might prefer a darker brown premix. Our premix
was more suitable for the latter formations. However, there is a
possibility of using a small amount of colorant to lighten the
color of the premix. In such cases, the L*a*b* data in Table 1
could provide guidance to the amount of colorants needed for
matching the color of the product.
As seen in the SEM images (Fig. 1), the uniformity of
coating for chitosan microcapsules increased as the amount
of iron was increased from 15 to 20 to 30%; however, at
40% iron loading, the coating disintegrated with a significant-
ly reduced size of the microcapsule. On the other hand,
Eudragit microcapsules formed the best microcapsules at
40% iron loading and the uniformity of coating increased on
increasing iron loading. The average size of the microcapsules
was evaluated using image analysis of these SEM images and
varied between 3 and 5 μm, with no significant difference
(p > 0.05) between the sizes of the microcapsules of various
formulations, except chitosan 40%, whose microcapsules
were between 0.5 and1.5 μm and were significantly
(p < 0.05) smaller than the others. The smaller size of the
microcapsules at 40% ferrous sulfate loading, are indicative
of the fact that these microcapsules due to the low amount of
chitosan (1% w/w solids) present relative to the amount of
iron, in contrast to high amount (22% w/w total solids) of
coating material in Eudragit-basedmicrocapsules. At this high
level of encapsulate loading, the encapsulant was probably
insufficient to provide a good film, and hence, there was no
impedance to mass transfer and the particles kept on shrinking
further, resulting in smaller particles with imperfect capsules
(Amiri-rigi et al. 2011). From these results, it can be conclud-
ed that chitosan microcapsules with 30% ferrous sulfate load-
ing and Eudragit with 40% ferrous sulfate loading resulted in
producing desirable microcapsules for our purposes with
higher iron loading and particle uniformity.
Table 1 Characteristics of the various microcapsules prepared
Sample Process yield (%) Process
output (g/l)




Chitosan 15% 721 16.61 64.11 7.41 29.61 891 981 1.31
Chitosan 20% 752 18.02 58.42 12.32 38.62 692 952 1.52
Chitosan 30% 683 17.72 57.72 15.62 39.22 871 913 1.03
Chitosan 40% 742 20.73 51.72 16.42 44.33 933 952 1.03
Eudragit 10% 752 123.74 94.33 −4.23 33.54 943 913 1.52
Eudragit 20% 731 131.45 87.13 4.11 41.13 824 874 1.03
Eudragit 30% 683 132.65 71.64 10.51 43.73 933 854 1.23
Eudragit 40% 742 155.46 62.91 15.32 46.44 995 942 2.44
Same values in superscript within a column indicate groups of means which are not statistically different from each other according to Duncan’s multiple
range test
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Iron Content, Iron Bioavailability, Encapsulation
Efficiency, and Reverse-Enteric Behavior
Spray drying as a technology involves rapid evaporation of
small droplets. The concentration of the various constituents
in the dried powder may change, depending on the flow rate of
the aspirator, the efficiency of the cyclone separator, and other
process parameters. Therefore, it is important to investigate
the iron content in the spray solution before and then in the
prepared microcapsules after spray drying. Figure 2 shows the
total iron content of the spray solutions and the prepared mi-
crocapsules. There was no significant difference (p > 0.05)
between the means of the iron content of the microcapsules
and spray solution for chitosan. This is expected, if all of the
spray solution is dried to form particles of similar composi-
tion. However, for Eudragit, it was seen that there was a sig-
nificant difference (p < 0.05) in the iron content of the pre-
pared microcapsules with increase in iron loading. This could
be explained by the non-homogenity during the spray drying
process. The lighter microcapsules formed with low iron
Chitosan 0% Chitosan 15%
Chitosan 20% Chitosan 30% Chitosan 40%
Eudragit 0% Eudragit 10%
Eudragit 20% Eudragit 30% Eudragit 40%
Fig. 1 SEM images of the prepared microcapsules (magnification shown in image)
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content escaped the system through the air exhaust, leaving
particles collected at the bottom enriched in the heavier iron.
Figure 2 also suggests that Eudragit microencapsulation
proved efficient as microcapsules with up to 9.6% w/w iron
content could be obtained, which was less than those created
earlier in our group (Li et al. 2010; Romita et al. 2011) using
macroencapsulation technology of agglomeration and extru-
sion processes (which produce microcapsules with around
16–18% w/w iron content), but might still be acceptable as a
microencapsulation approach. As seen in the BMorphology of
the PreparedMicrocapsules^ section, the uniformity of encap-
sulation was also better for Eudragit microcapsules. The ad-
vantage of the Eudragit microcapsules is also further enhanced
by the better process output of Eudragit due to the significant-
ly higher total solid content (about 20 times) of the Eudragit
spray solutions than that of the chitosan solution, as explained
in the BProcess Yield^ section.
Figure 3 shows the percentage of iron release from the
microcapsules in pH 1 HCl solution. This pH is often used
in in vitro bioavailability studies, as it approximates the avail-
ability of iron inside the stomach. Most of the microcapsules
released almost 100% of the iron present in the samples within
2 h at pH 1. In general, chitosanmicroparticles exhibited faster
release than Eudragit microcapsules. More than 90% of the
iron was released within 15 min for all microcapsules, except
those with 20% ferrous sulfate loading. On the other hand, for
chitosan, only BChitosan 40%^ could achieve more than 90%
iron release. There was a delay between 15 and 30 min for
release of 90% iron for the chitosan microcapsules, as com-
pared to the Eudragit under stomach conditions. While this
delayed release could be a property of choice for some specific
applications, a faster availability in pH 1 solution is generally
desirable for food iron fortification initiatives, with moderate
pH levels. In vitro bioavailability of the samples was analyzed
by calculating the percentage of iron released after 30 min,
which is the approximate minimal time spent by food in the
stomach. For Eudragit samples, iron was almost completely
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Fig. 3 Iron released from the
various chitosan and Eudragit
microcapsules at pH 1 as
measured via release in 0.1 NHCl
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sulfate loading with 82% bioavailability. On the other hand,
for chitosan samples, the iron bioavailability was 89, 69, 87,
and 93% for 15, 20, 30, and 40% ferrous sulfate loading,
respectively. In general, the bioavailability of iron was higher
for Eudragit samples.
Figure 4 details the pH release behavior in pH 4 solution.
The iron release in pH 4 is generally used to check the stability
of the coating for iron that is insoluble at pH 7, but might still
be released under conditions which are less acidic. Under mild
stirring at pH 4, asmuch as 67–94% of ironwas released in 2 h
for chitosan microcapsules, as compared to 53–70% iron re-
leased for Eudragit encapsulated particles. Thus, it is seen that
for comparing the coating integrity, Eudragit microcapsules
offer better protection than their chitosan counterparts. Forty
percent Eudragit encapsulated particles, with only 53% iron
released, was the most effective coating tested.
Figure 5 depicts the release behavior in pH 7 solution. This
represents the amount of iron released during soaking/
cooking/processing of food in water. It must be mentioned
that this release behavior does not take into account the effect
of temperature. Human saliva has a healthy pH around 7.4, but
this can vary from 5.9–7.9 (Feller and le Petit 1977; Ritschel
and Thompson 1983). Thus, iron release in neutral pH also
approximates the amount of iron that would be released in the
mouth. However, any release of iron before swallowing will
directly affect the taste of the food. Only 10–18% of the iron in
chitosan microencapsulated particles was released with gentle
shaking in a pH 7 solution for 2 h. On the other hand, for
Eudragit particles, 12–25% iron particles were released in
the same time. It is notable that Eudragit microparticles with
40% ferrous sulfate loading gave the lowest iron release, 12%
at pH 7 depicting better coating integrity of these microparti-
cles. Although, the best protection against neutral pH condi-
tions was achieved by chitosan 15 and 20% iron loaded
microcapsules.
As a result of the observations for pH 7, the encapsulation
efficiency of chitosan microcapsules (91–97%) was found
better than that of Eudragit microcapsules (85–94%)
(Table 1). This suggests the superior protection offered by
chitosan microcapsules under neutral pH conditions.
However, to be used as a reverse-enteric coating material,
release at pH 1 is also an important factor to consider to ensure
high bioavailability. As shown in Figs. 3, 4, and 5, the amount
of the iron released from these microcapsules was high at pH 1
and then decreased as the pH increased from 1 to 7, as expect-
ed with reverse-enteric coating. This behavior is optimal for
iron release and absorption. The reverse entericity (RE) ratio
of the various microcapsules were computed based on release
after 1 h and presented in Table 1. Eudragit 40% microcap-
sules had the maximum RE ratio (2.4). Amongst the chitosan
microcapsules, 20% ferrous sulfate loading chitosan micro-
capsules had the maximum RE ratio (1.5), again confirming
that Eudragit at 40% was the most effective coating tested.
Release Parameters for the Prepared Microcapsules
It is important to characterize the release behavior by fitting it
to well-known models in the literature to provide data for
mathematical modeling of the release behavior of our iron
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Fig. 4 Iron released from the
various chitosan and Eudragit
microcapsules at pH 4 as
measured via release in 0.0001 N
HCl
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pH for these iron microcapsules for a period of 2 h with var-
ious models, and the fitted parameters are provided in
Table 2. Nevertheless, the zero-order and first-order
models are the most common and well-understood models
used for modeling in chemical engineering investigations
(Kitazawa et al. 1977; Mulye and Turco 1995); other
more sophisticated models can throw a greater light into
the active mass transfer phenomenon. Thereby, Higuchi
model (Higuchi 1963), Hixson-Crowell model (Hixson
and Crowell 1931), and Weibull Model (Langenbucher
1972) were also tested.
The mean of the R2 for the fit between the zero-order and
first-order models ranged around 0.84 ± 0.12 and 0.83 ± 0.14,
respectively, suggesting that neither could produce a fit, but,
as these R2 are within acceptable range of > 0.7, they could be
used for simpler mathematical modeling purposes. Although,
this demonstrates that both zero- and first-order models are
equally acceptable, the values of the release predicted at
t = 0 is given by the constants C0 and C1. While C1 ranged
between 3.8 ± 0.8, C0 showed a greater variability with their
means around 45.7 ± 34.6. Thus, it can be concluded that the
first-order model was a better choice than the zero-order mod-
el, as the release at t = 0 should not vary much from 0. This is
also evident in the general applicability scenarios for these
models. Whereas the zero-order model is more applicable to
pharmaceutical dosage forms that do not disaggregate and
release the drug slowly (Varelas et al. 1995), the first-order
model is applicable in the case of porous drug matrices. Our
system is closed to a first-order model, where the amount of
drug released is proportional to the amount of drug left over in
the interior and decreased with time.
Amongst all the models tried in this study, Higuchi model
gave the best fit (mean R2 = 0.95 ± 0.03). Mean R2 for the
Hixson-Crowell and Weibull models ranged around
0.84 ± 0.12 and 0.81 ± 0.13, respectively, and were similar
to that for the first-order model. Yet, in terms of the absolute
value of the means, the fitting of the models may be arranged
as follows: Higuchi > Hixson-Crowell > first order > Weibull.
Thus, Higuchi (1963) model was found to be the best fit iron
release data from our system. Higuchi model has been tradi-
tionally developed to study the release of water-soluble and
low-soluble drugs incorporated in semi-solid and/or solid ma-
trices. This model describes the drug release as a diffusion
process described by Fick’s law, with the dissolution depen-
dent on the square root of the time. Higuchi model has been
used inmany pharmaceutical systems such as those in the case
of transdermal systems (Costa and Lobo 2001) and in matrix
tablets with water-soluble drugs (Schwartz et al. 1968). Our
iron fortification premix coated with chitosan and Eudragit
polymers resembles the latter case, iron sulfate being the
water-soluble drug in our study. Being based on Fick’s law,
square of the Higuchi dissolution constant (Kh) is directly
related to the diffusivity from the matrix (Costa and Lobo
2001) and can be used for such calculations. Obviously, the
relation between the dissolution constant and the diffusivity
also depends on the surface properties of the material includ-
ing shape, size, and sphericity. Based on the values of Kh, it
can be concluded that, as compared to chitosan, Eudragit sam-
ples offered better diffusivity under stomach conditions at pH
1 (mean Kh = 10.93 ± 0.58 for chitosan and mean
Kh = 11.27 ± 0.63 for Eudragit), and lower diffusivity at pH
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Fig. 5 Iron released from the
various chitosan and Eudragit
microcapsules at pH 7 as
measured via release in a
phosphate buffer of pH 7
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Kh = 6.55 ± 1.35 for Eudragit). However, at pH 7, which is
important for the taste masking behavior, chitosan provided a
better impediment to iron release (mean Kh = 1.13 ± 0.46 for
chitosan and mean Kh = 1.87 ± 0.53 for Eudragit). Yet, it must
be mentioned that Eudragit with 40% loading had a
Kh = 1.13 at pH 7, which was same as that for chitosan.
Thus, overall, Eudragit 40% is found to be a better choice
for food fortification purposes. These calculations confirm
results found in the previous sections.
It is important to understand that the high R2 associated
with Higuchi model cannot be used for comparison with other
models. Higuchi model is a constrained model with only one
parameter Kh represented by the slope of the (y-t
0.5) curve,
whereas, other models have two-parameters with the slope
of the curve yielding the value of one parameter (K0, K1, Ks,
b) and the constant yielding the value of the other parameter
(C0, C1, Cs, −log a). Due to this, essentially during curve
fitting with excel, during Higuchi model, the constant is
forced to 0, yielding a higher emphasis on the origin points
(y = t = 0). Under these circumstances, R2 is computed with a
slightly different formula, due to which a higher value of R2 is
obtained. Hence, it is important to check other models as well.
Weibull model fitted the worst amongst the models compared,
yet its R2 was only slightly lower than other models, and this
model could still be considered acceptable for deriving mean-
ingful deductions. Since, the b* values of the model were less
than 1 in our case, the dissolution profile can be understood to
be parabolic, with a higher initial slope, and after that consis-
tent with exponential profile. Yet, again, for in vitro studies,
Weibull model has been under severe criticism (Christensen
et al. 1980; Pedersen and Myrick 1978) as it could never
adequately characterize the dissolution kinetic properties of
the drug due to the absence of any single parameter related
to the dissolution rate of the drug. Our lower R2 values can be
attributed to this phenomenon. Hixson-Crowell model was a
better fit as compared to Weibull model, while its fit to the
Higuchi model could not be compared. Hixson and Crowell
(1931) model assumes that the release rate is limited by the
drug particle dissolution rate and not diffusion process
through the matrix. The applicability of both Higuchi and
Hixson-Crowell models suggests that both the mechanisms
of slowed release due to diminishing surface of the drug par-
ticles during the dissolution and the diffusion process through
the barrier created by the coating material are of concern for
Table 2 Parameters and Determination Coefficients of the various models tested
Model Zero order First order Higuchi Hixson-Crowell Weibull Model
pH K0 C0 R
2 K1 C1 R
2 Kh R
2 Ks Cs R
2 b a R2
Chitosan 15% 1 0.25 73.38 0.69 0.040 4.10 0.84 10.99 0.95 0.021 3.23 0.89 0.68 5.40 0.88
4 0.11 57.53 0.78 0.003 3.75 0.79 7.83 0.93 0.003 3.49 0.78 0.15 1.77 0.83
7 0.08 0.12 0.95 0.001 4.60 0.95 0.72 0.91 0.001 4.64 0.95 0.66 307.74 0.86
Chitosan 20% 1 0.21 68.98 0.78 0.012 3.52 0.85 10.11 0.94 0.010 3.19 0.83 0.35 2.20 0.81
4 0.16 47.93 0.89 0.004 3.97 0.89 7.11 0.95 0.004 3.75 0.89 0.20 2.52 0.75
7 0.07 1.43 0.84 0.001 4.59 0.85 0.77 0.96 0.001 4.62 0.85 0.85 556.28 0.85
Chitosan 30% 1 0.15 82.58 0.90 0.021 3.14 0.99 11.17 0.93 0.013 2.71 0.97 0.40 1.76 0.97
4 0.27 56.78 0.83 0.010 3.82 0.87 9.25 0.96 0.010 3.55 0.86 0.42 3.81 0.95
7 0.16 1.74 0.94 0.002 4.59 0.95 1.64 0.97 0.003 4.62 0.94 0.92 340.47 0.98
Chitosan 40% 1 0.06 91.74 0.83 0.015 2.30 0.77 11.45 0.91 0.008 2.09 0.79 0.22 0.73 0.68
4 0.20 67.41 0.96 0.013 3.70 0.86 9.86 0.94 0.011 3.31 0.90 0.32 2.13 0.76
7 0.09 4.81 0.87 0.001 4.56 0.87 1.38 0.99 0.001 4.57 0.87 0.41 46.37 0.90
Eudragit 10% 1 0.05 92.64 0.87 0.033 2.90 0.65 11.51 0.91 0.011 2.17 0.72 0.32 0.98 0.51
4 0.22 35.78 0.96 0.005 4.19 0.95 6.28 0.97 0.006 4.03 0.95 0.33 5.22 0.93
7 0.12 6.59 0.95 0.001 4.54 0.95 1.86 0.99 0.002 4.54 0.95 0.37 29.43 0.90
Eudragit 20% 1 0.19 72.18 0.78 0.034 4.27 0.62 10.34 0.94 0.017 3.38 0.68 0.49 3.17 0.52
4 0.14 51.88 0.67 0.004 3.88 0.72 7.51 0.94 0.004 3.64 0.70 0.23 2.57 0.82
7 0.14 7.66 0.86 0.002 4.53 0.87 2.20 0.99 0.002 4.52 0.87 0.45 32.70 0.93
Eudragit 30% 1 0.07 90.85 0.81 0.025 2.72 0.85 11.46 0.91 0.011 2.26 0.84 0.30 0.99 0.65
4 0.08 58.23 0.82 0.002 3.74 0.81 7.65 0.92 0.002 3.48 0.81 0.10 1.50 0.73
7 0.15 7.40 0.91 0.002 4.53 0.92 2.30 0.99 0.003 4.53 0.92 0.49 37.70 0.97
Eudragit 40% 1 0.05 94.60 0.41 0.027 1.26 0.37 11.76 0.91 0.010 1.61 0.44 0.40 0.99 0.64
4 0.25 20.81 0.88 0.004 4.40 0.87 4.74 0.98 0.005 4.31 0.88 0.45 13.19 0.87
7 0.06 4.60 0.95 0.001 4.56 0.95 1.13 0.97 0.001 4.57 0.95 0.27 32.87 0.80
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modeling the release behavior of microencapsulated iron
microparticles.
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Conclusions
This study presents the possibility of using spray drying
for the purposes of food fortification. Spray drying-based
encapsulation was attempted using two coating materials
and their iron release was modeled with various well-
known dissolution models. Higuchi model was found best
to model the iron release behavior of these spray drying
encapsulated microcapsules. The applicability of Higuchi
and Hixson-Crowell models suggests a transport phenom-
enon limited both by the dissolution and diffusion pro-
cesses. Spray drying encapsulated microcapsules, particu-
larly the Eudragit encapsulated microcapsule with 40%
iron loading, could provide up to 9.6% w/w of iron, which
the same order of magnitude as those produced by extru-
sion processes. All samples had desirable bioavailability,
high encapsulation efficiency, good coating integrity, and
low release in neutral pH. Eudragit encapsulated micro-
capsules with 40% ferrous sulfate loading and chitosan
encapsulated microcapsules with 30% ferrous sulfate
loading were found to be the best candidates for possible
application in future research. It is noteworthy that the
Eudragit coating, due to higher solid content, can handle
higher amount of iron payload. Despite its competitive
properties and better encapsulation efficiency than
Eudragit, process yield of Chitosan was low, due to the
relatively high viscosity at low concentration and low sol-
id content, suggesting a possibility of exploring secondary
polymers with chitosan in future work. The new method-
ology developed for studying the iron release of microen-
capsulated microparticles could be used in future applica-
tions in food fortification research.
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